First Time Loading...

IRadimed Corp
NASDAQ:IRMD

Watchlist Manager
IRadimed Corp Logo
IRadimed Corp
NASDAQ:IRMD
Watchlist
Price: 42 USD 3.42% Market Closed
Updated: May 2, 2024

IRadimed Corp
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

IRadimed Corp
Operating Income Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
IRadimed Corp
NASDAQ:IRMD
Operating Income
$20m
CAGR 3-Years
N/A
CAGR 5-Years
27%
CAGR 10-Years
22%
Becton Dickinson and Co
NYSE:BDX
Operating Income
$2.1B
CAGR 3-Years
1%
CAGR 5-Years
-5%
CAGR 10-Years
5%
Boston Scientific Corp
NYSE:BSX
Operating Income
$2.5B
CAGR 3-Years
46%
CAGR 5-Years
7%
CAGR 10-Years
10%
Stryker Corp
NYSE:SYK
Operating Income
$4.5B
CAGR 3-Years
17%
CAGR 5-Years
7%
CAGR 10-Years
7%
Abbott Laboratories
NYSE:ABT
Operating Income
$6.6B
CAGR 3-Years
-1%
CAGR 5-Years
11%
CAGR 10-Years
13%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Income
$1.9B
CAGR 3-Years
16%
CAGR 5-Years
9%
CAGR 10-Years
11%

See Also

What is IRadimed Corp's Operating Income?
Operating Income
20m USD

Based on the financial report for Dec 31, 2023, IRadimed Corp's Operating Income amounts to 20m USD.

What is IRadimed Corp's Operating Income growth rate?
Operating Income CAGR 10Y
22%

Over the last year, the Operating Income growth was 28%.